Agonist-dependent and -independent dopamine-1-like receptor signalling differentially regulates downstream effectors

FEBS J. 2014 Nov;281(21):4792-804. doi: 10.1111/febs.13018. Epub 2014 Sep 26.

Abstract

De-regulation of energy metabolism by the dopaminergic system is linked to neurological diseases such as schizophrenia and bipolar disorder. Inverse agonists are thought to be more beneficial in treating neurological diseases than neutral antagonists, but only limited experimental data are available regarding the impact of constitutive signalling on energy metabolism. The aim of the present study was to assess the impact of constitutive dopamine-1 receptor (D1R) and dopamine-5 receptor (D5R) signalling on downstream targets in transiently and stably transfected HEK293T cells. The high constitutive activity of D5R was accompanied by increased Na(+)/H(+) exchanger (NHE) activity and accelerated glucose degradation due to increased transcription and translation of the Na, K-ATPase-α3 and NHE-2. Chronic treatment with an agonist increased the mRNA levels of the α2 Na,K-ATPase, NHE-2 and NHE-3. Constitutive D5R activation of a cAMP response element-based reporter was regulated by G protein-coupled receptor kinase 2, but this did not affect the cell-surface abundance of the receptor. Our data suggest that constitutive and agonist-induced activity of D5R differentially regulates the activity and expression of proteins.

Keywords: GPCR; cAMP; constitutive activity; dopamine-1 receptor; dopamine-5 receptor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Compartmentation
  • Cyclic AMP / physiology
  • Dopamine Agonists / pharmacology*
  • G-Protein-Coupled Receptor Kinase 2 / physiology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Glucose / metabolism
  • HEK293 Cells
  • Humans
  • Ion Transport / drug effects
  • Promoter Regions, Genetic
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Dopamine D1 / agonists
  • Receptors, Dopamine D1 / physiology*
  • Receptors, Dopamine D5 / agonists
  • Receptors, Dopamine D5 / physiology*
  • Recombinant Fusion Proteins / metabolism
  • Response Elements
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers / biosynthesis
  • Sodium-Hydrogen Exchangers / genetics
  • Sodium-Potassium-Exchanging ATPase / biosynthesis
  • Sodium-Potassium-Exchanging ATPase / genetics
  • Transfection

Substances

  • Dopamine Agonists
  • RNA, Messenger
  • Receptors, Dopamine D1
  • Recombinant Fusion Proteins
  • SLC9A2 protein, human
  • SLC9A3 protein, human
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers
  • Receptors, Dopamine D5
  • Cyclic AMP
  • GRK2 protein, human
  • G-Protein-Coupled Receptor Kinase 2
  • ATP1A2 protein, human
  • Sodium-Potassium-Exchanging ATPase
  • Glucose